Moderna’s experimental coronavirus vaccine has built immunity in monkeys and protected them from being infected, according to results of a new trial study announced by the company Tuesday.
Moderna’s experimental coronavirus vaccine has built immunity in monkeys and protected them from being infected, according to results of a new trial study announced by the company Tuesday.
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
We'll send a verification code to %EMAIL%.
Get the best of The Washington Informer directly in your email inbox.
Sending to: